Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

How Much Does a CJC-1295 with DAC Cycle Cost? (2026 Calculat

How Much Does a CJC-1295 with DAC Cycle Cost? Pick your protocol and duration — we'll show you how many vials you need and the total cost from 5 vendors. Quick Answer A 12-week standard weekly (12 weeks) cycle starts at $250.75 5 vials from Ion Peptide at $59.

How Much Does a CJC-1295 with DAC Cycle Cost?

Pick your protocol and duration — we'll show you how many vials you need and the total cost from 5 vendors.

Quick Answer

A 12-week standard weekly (12 weeks) cycle starts at $250.75

5 vials from Ion Peptide at $59.00 per vial

What Dose and Duration Are You Running?

Which Vendor Is the Best Deal for This Cycle?(5 vendors)

Best CJC-1295 with DAC Vendors of 2026 →

Ranked by price, purity testing, and buyer trust

Best Deal on CJC-1295 with DAC →

All vendors sorted by $/mg — find the best deal

Best CJC-1295 Vendors of 2026 →

Calculate the Cost of Your CJC-1295 Cycle →

Pick your dose and duration — see the total with supplies

Disclaimer: This calculator is for informational purposes only. Prices are updated regularly but may change. These peptides are sold for research purposes only and are not intended for human consumption. Always consult a healthcare provider before starting any research protocol.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosages

Dosages in research are individualized and typically administered via subcutaneous injection. Common protocols include: 100 mcg per injection, 2 times per week. Cycling regimens (e.g., 8-12 weeks on, 4 weeks off) to prevent desensitization. Often dosed at bedtime to align with natural GH pulses. Dosing should be tailored to research goals and subject response, with careful monitoring.
STORAGE

Considerations for Researchers: Handling and Storage

Working with any research peptide, including the CJC-1295 GHRH analog with DAC, requires careful attention to handling and storage protocols to maintain its stability and efficacy. We've seen firsthand how improper storage can compromise a compound, rendering it useless for sensitive experiments. Here's what we recommend based on our extensive experience: Storage of Lyophilized Powder: The peptide should be stored in a cool, dark, and dry place, ideally at -20°C or colder. This prevents degradation over time. Keep it away from light and moisture, which are its primary enemies. Reconstitution: When you're ready to use the CJC-1295 GHRH analog with DAC, it's typically reconstituted with a sterile, bacteriostatic solution. For example, Bacteriostatic Reconstitution Water (bac) is a common choice, helping to inhibit bacterial growth and preserve the solution for a longer period. Always use sterile techniques to prevent contamination. Storage of Reconstituted Solution: Once reconstituted, the peptide solution is much less stable than its lyophilized form. It should be stored refrigerated (2-8°C) and used within a specific timeframe, usually a few weeks. Avoid repeated freezing and thawing, as this can degrade the peptide structure. It's comprehensive. Handling: Always handle peptides with clean, sterile equipment. Avoid shaking the vial vigorously during reconstitution; instead, gently swirl it to dissolve the powder. This helps prevent denaturation of the delicate peptide struct…
02

Question drills

Open a question for its connected answer.

01What If CJC-1295 Is Combined with Exogenous Growth Hormone?+

This combination is redundant and potentially counterproductive. Exogenous GH administration suppresses endogenous pituitary GH secretion through negative feedback at the hypothalamus. CJC-1295 works by stimulating the pituitary to release its own GH. If the pituitary is already suppressed by exogenous GH, CJC-1295 has no secretory capacity to amplify. The two compounds work through incompatible mechanisms. Research protocols should use one or the other, not both simultaneously.

SOURCE / realpeptides.co ↗
02What If I Experience Joint Stiffness or Water Retention in Week Three?+

These are classic signs of elevated IGF-1 and extracellular fluid expansion, which GH analogs cause through sodium retention in the kidneys. Mild edema (slight hand or ankle puffiness) typically resolves within 2–3 weeks as your body adjusts, but persistent joint stiffness suggests you're dosing too high for your current IGF-1 baseline. Drop to 1mcg/kg twice weekly and retest IGF-1 at week 6. If you're already in the 280–300ng/mL range, further elevation adds minimal benefit and increases side effect probability. Joint pain that worsens or doesn't resolve after dose reduction warrants stopping the cycle and consulting a medical professional.

SOURCE / realpeptides.co ↗
03What If I'm Stacking CJC-1295 with a GHRP Like Ipamorelin — Does Timing Change?+

Yes. Stacking changes the equation. GHRPs (growth hormone-releasing peptides like ipamorelin, GHRP-2, or hexarelin) work via a different receptor (ghrelin receptor) and can induce GH pulses independent of circadian timing. When stacking CJC-1295 with a GHRP, most research protocols dose both peptides together 2–3 times daily: upon waking, post-workout, and before bed. The GHRP creates the pulse; CJC-1295 amplifies it. For stacked protocols, nighttime dosing remains the largest dose, but the single-dose-before-bed rule no longer applies.

SOURCE / realpeptides.co ↗
04What If IGF-1 Levels Don't Elevate as Expected After CJC-1295 Administration?+

Measure baseline IGF-1 before dosing and retest at 96 hours. Not 24 or 48 hours. If IGF-1 remains flat at the 96-hour mark, the issue is likely either receptor saturation from prior GH exposure, hepatic GH receptor downregulation, or peptide degradation due to improper storage. CJC-1295 with DAC must be stored at −20°C before reconstitution; once mixed with bacteriostatic water, it remains stable at 2–8°C for 28 days but degrades rapidly above 8°C. A single temperature excursion can denature the peptide structure entirely.

SOURCE / realpeptides.co ↗
05What If the Syringe Markings Don't Align with My Calculated Dose Volume?+

Round to the nearest measurable increment rather than attempting to estimate between markings. If your calculated injection volume is 0.245mL (24.5 units) and your syringe measures in whole units, draw 25 units instead of trying to eyeball the halfway point between 24 and 25. The rounding error. 0.005mL or roughly 2% of dose. Is smaller than the variability introduced by attempting to measure fractional syringe units by eye. For protocols requiring doses that consistently fall between syringe markings, reconstitute with a different water volume to shift the concentration until your target doses align with whole syringe units.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Purity Standards and Quality Assurance in Research-Grade CJC-1295 with DAC

The integrity of research data depends fundamentally on the purity and identity of the compounds used. For research-grade CJC-1295 with DAC, the analytical standards of the field establish that peptide purity should be verified at or above 98% by high-performance liquid chromatography (HPLC), with molecular identity confirmed by mass spectrometry (MS). Additional quality markers include low endotoxin levels (critical for in vivo studies in animal models) and verified sterility for any solution-phase preparations. Palmetto Peptides provides Certificates of Analysis (COA) for all research compounds, including HPLC purity traces and MS verification data, enabling researchers to confirm identity and quality before incorporating the compound into experimental protocols. For detailed guidance on evaluating COAs and supplier quality, see our articles on sourcing high-purity CJC-1295 with DAC and CJC-1295 with DAC purity standards and quality control.

RESEARCH

History and Development of CJC-1295 with DAC as a Research Peptide

Research Notice: This article covers the history and scientific development of CJC-1295 with DAC — available from Palmetto Peptides for laboratory use only. Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines. DISCLAIMER: This article is for educational and scientific research reference purposes only. All compounds discussed are not approved by the FDA for use in humans or animals. All data discussed here reflects preclinical animal research or laboratory use. Palmetto Peptides sells these compounds exclusively for in vitro and preclinical laboratory research. Nothing in this article constitutes medical advice. Last Updated: May 18, 2026 | Reading Time: Approximately 13 minutes | Author: Palmetto Peptides Research Team

05

Product & matchup locker

Linked catalog and comparison files.